Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(43%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
14%
Ph not_applicable
5
71%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(2)
Other(2)

Detailed Status

Recruiting3
unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

unknown229%
completed229%
recruiting343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
7